ClinicalTrials.Veeva

Menu

Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) During Pregnancy

The Pennsylvania State University (PENNSTATE) logo

The Pennsylvania State University (PENNSTATE)

Status

Completed

Conditions

Pregnancy Related
Cardiovascular Diseases
Sedentary Behavior

Treatments

Behavioral: Maternal CVH Intervention

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05822531
STUDY00021577
1UG3HL162971-01 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This pilot study aims to examine the feasibility and acceptability of adding a cardiovascular health module to the existing Nurse Family Partnership (NFP) home visitation program delivered by trained nurses in the Northern Appalachian region of Central Pennsylvania.

Full description

The Promoting Cardiovascular Health of Northern Appalachian Women During and After Pregnancy: Pilot Study is a single arm pilot study that will enroll pregnant women (<28 weeks' gestation) participating in the NFP home visitation program in the Northern Appalachian region of Central Pennsylvania. This pilot study will include an enhanced version of the NFP standard care plan delivered by trained nurses to promote cardiovascular health among women by targeting decreased sedentary time and enhanced physical activity (and where applicable smoking cessation) during and after pregnancy. This pilot study will also examine the feasibility and acceptability of digital devices (actigraphy, digital scale, blood pressure monitor) during this same time period.

Enrollment

12 patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Nulliparous pregnant woman
  2. Age ≥ 18 years old
  3. Enrolled in and receiving the Nurse-Family Partnership program through the Geisinger Clinic or UPMC Home Health Care of Central PA
  4. English speaking
  5. Women with a singleton viable pregnancy confirmed by NFP home visitors
  6. Access to reliable internet service required for data collection
  7. A minimum of 5 women with use of nicotine containing products (cigarette, cigar, hookah, chewing tobacco, e-cigarette, patch) within the past 3 months

Exclusion criteria

  1. Unable or unwilling to comply with the study visits and procedures
  2. Participation in a concurrent interventional study
  3. Diagnosis of cancer
  4. A personal history of complex congenital heart disease
  5. A fetus in the current pregnancy with known chromosomal abnormalities or birth defects inconsistent with survival to 2 years will be excluded

Trial design

Primary purpose

Prevention

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

12 participants in 1 patient group

Maternal Cardiovascular health (CVH) Intervention
Experimental group
Description:
The pilot maternal CVH intervention will be delivered by NFP partners starting as early as NFP program enrollment in the first trimester after confirmation of a viable pregnancy and no later than the 28th week of pregnancy and will continue up to 6 months postpartum. The visit schedule will be consistent with the NFP visit structure to deliver intervention content at regularly scheduled visits that are typically 60 minutes long (weekly visits for the first month following enrollment followed by twice monthly visits until delivery). The pilot study will include an enhanced behavioral component target decreased sedentary time and increase physical activity and utilizing a technology/monitoring component. All women be monitored using a wrist-worn actigraphy device to record daily activity, intermittent home blood pressure self-monitoring, intermittent home weight self-monitoring, and carbon monoxide monitoring administered by the NFP nurse.
Treatment:
Behavioral: Maternal CVH Intervention

Trial documents
1

Trial contacts and locations

2

Loading...

Central trial contact

Richard S Legro, MD; Ian M Paul, MD, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems